Related News
Sex hormone explains higher liver cancer risk in men
Source: Agencies |
May 19, 2010, Wednesday
|
Online Edition
Online Edition
MALE sex hormones may explain why men who suffer from the hepatitis B liver disease are more likely to develop liver cancer than women, researchers in Taiwan have found.
In a paper published in the journal Science yesterday, the researchers said hepatitis B viruses attach themselves to receptors of the male sex hormone androgen before going on to damage liver tissue and cause cancer.
"The findings indicate that using drugs to destroy ... androgen receptors could be a new way to battle liver cancer at an early stage," they wrote.
Liver cancer is the fifth most common cancer and the third leading cause of global cancer death.
Hepatitis B virus infection, which is endemic in many Asian countries including China, is a leading cause of liver cancer and accounts for half of liver cancer cases worldwide.
Men are up to seven times more likely than women to develop liver cancer. Among hepatitis B virus carriers, men are up to three times more likely to develop liver cancer than women.
Led by Ming-Heng Wu at the Institute of Basic Medical Sciences in National Cheng Kung University in Tainan, Taiwan, researchers found that hepatitis B viruses have a special DNA sequence which draws it to androgen receptors.
"The androgen receptors in liver cells bind to this sequence and trigger a cascade of damage to liver tissue," they explained.
In their experiment, the researchers created mice that were infected with the hepatitis B virus and could easily develop liver tumours upon exposure to cancer-causing agents.
Some of these were genetically modified to be lacking in androgen receptors in their livers.
By week 22 in the experiment, more than 90 percent of those mice with androgen receptors had developed liver tumours compared to 27 percent of the mice without androgen receptors.
Tinkering with the receptors did not change overall androgen levels or leave any obvious toxic effects in the mice.
"Targeting the androgen receptor rather an androgen could be a promising therapy for liver cancer," the researchers said.
In a paper published in the journal Science yesterday, the researchers said hepatitis B viruses attach themselves to receptors of the male sex hormone androgen before going on to damage liver tissue and cause cancer.
"The findings indicate that using drugs to destroy ... androgen receptors could be a new way to battle liver cancer at an early stage," they wrote.
Liver cancer is the fifth most common cancer and the third leading cause of global cancer death.
Hepatitis B virus infection, which is endemic in many Asian countries including China, is a leading cause of liver cancer and accounts for half of liver cancer cases worldwide.
Men are up to seven times more likely than women to develop liver cancer. Among hepatitis B virus carriers, men are up to three times more likely to develop liver cancer than women.
Led by Ming-Heng Wu at the Institute of Basic Medical Sciences in National Cheng Kung University in Tainan, Taiwan, researchers found that hepatitis B viruses have a special DNA sequence which draws it to androgen receptors.
"The androgen receptors in liver cells bind to this sequence and trigger a cascade of damage to liver tissue," they explained.
In their experiment, the researchers created mice that were infected with the hepatitis B virus and could easily develop liver tumours upon exposure to cancer-causing agents.
Some of these were genetically modified to be lacking in androgen receptors in their livers.
By week 22 in the experiment, more than 90 percent of those mice with androgen receptors had developed liver tumours compared to 27 percent of the mice without androgen receptors.
Tinkering with the receptors did not change overall androgen levels or leave any obvious toxic effects in the mice.
"Targeting the androgen receptor rather an androgen could be a promising therapy for liver cancer," the researchers said.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
